Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
113 valent conjugated pneumococcal vaccine----1件: 265 💬
2150 mg GSK1265744B----1件: 265 💬
3300mg Gemcabene1件: Gemcabene---1件: 265 💬
43TC----2件: 256, 265 💬
5600mg Gemcabene1件: Gemcabene---1件: 265 💬
6Abacavir1件: Abacavir1件: Abacavir 💬--4件: 2, 135, 265, 325 💬
7Abacavir 300mg twice daily1件: Abacavir1件: Abacavir 💬--1件: 265 💬
8Abacavir sulfate2件: Abacavir,
Sulfate ion		1件: Abacavir 💬--1件: 265 💬
9Abacavir sulfate, Lamivudine and Zidovudine4件: Abacavir,
Lamivudine,
Sulfate ion,
Zidovudine		3件: Lamivudine ,
Zidovudine ,
Abacavir 💬		--1件: 265 💬
10ABC----2件: 256, 265 💬
11Acetate1件: Acetate---41件: 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
12ACETYL- L- CARNITINE1件: Levocarnitine1件: Levocarnitine 💬--1件: 265 💬
13Acetylcarnitine1件: Acetylcarnitine---2件: 2, 265 💬
14Acipimox1件: Acipimox1件: Acipimox 💬--2件: 78, 265 💬
15AKCEA-ANGPTL3-LRX----2件: 79, 265 💬
16Amplification by PCR and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene----1件: 265 💬
17Amprenavir1件: Amprenavir1件: Amprenavir 💬--1件: 265 💬
18Antiretroviral/Anti HIV----1件: 265 💬
19Aramchol1件: Aramchol---1件: 265 💬
20Atazanavir1件: Atazanavir1件: Atazanavir 💬--1件: 265 💬
21Atazanavir (ATV) + ritonavir (RTV), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (NRTIs)2件: Atazanavir,
Ritonavir		2件: Ritonavir ,
Atazanavir 💬		--1件: 265 💬
22Atazanavir (Reyataz)1件: Atazanavir1件: Atazanavir 💬--1件: 265 💬
23Atazanavir/Ritonavir2件: Atazanavir,
Ritonavir		2件: Ritonavir ,
Atazanavir 💬		--1件: 265 💬
24Atorvastatin1件: Atorvastatin1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬19件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
25Atorvastatin Calcium2件: Atorvastatin,
Calcium		1件: Atorvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬2件: 97, 265 💬
26ATV----1件: 265 💬
27Avandia administration for 6-12 weeks----1件: 265 💬
28AZT----2件: 94, 265 💬
29AZT/3TC----1件: 265 💬
30Baricitinib1件: Baricitinib1件: Baricitinib 💬2件: JAK1,
JAK2 💬		35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325 💬
31Berberine1件: Berberine---2件: 97, 265 💬
32BMS-232632----1件: 265 💬
33Caffeine1件: Caffeine2件: Caffeine ,
Caffeine hydrate 💬		11件: ADORA1,
ADORA2A,
PDE1B,
PDE2A,
PDE3A,
PDE3B,
PDE4A,
PDE4B,
PDE4C,
PDE4D,
PDE5A 💬		22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬8件: 2, 6, 21, 46, 78, 96, 97, 265 💬
34Calcium2件: Calcium,
Calcium carbonate		2件: Calcium carbonate ,
Calcium carbonate 💬		--27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 156, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
35Carnitine1件: Levocarnitine1件: Levocarnitine 💬--9件: 5, 13, 58, 86, 96, 97, 265, 298, 316 💬
36CD----8件: 6, 13, 46, 51, 63, 96, 97, 265 💬
37CD-4 guided therapy interruption----1件: 265 💬
38Cholic Acid1件: Cholic Acid1件: Cholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬4件: 20, 234, 265, 310 💬
39CoFactor----2件: 265, 288 💬
40Cofactor supplementation (thiamine, riboflavin, L-carnitine)3件: Levocarnitine,
Riboflavin,
Thiamine		3件: Riboflavin ,
Levocarnitine ,
Thiamine 💬		--1件: 265 💬
41COMBIVIR2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬		--1件: 265 💬
42Combivir (zidovudine [AZT] / lamivudine [3TC])2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬		--1件: 265 💬
43Continuation of current HAART (boosted protease inhibitor [PI] combination + 2 NRTIs)----1件: 265 💬
44Didanosine1件: Didanosine1件: Didanosine 💬--2件: 25, 265 💬
45Different HAART regimens----1件: 265 💬
46Diosmin1件: Diosmin1件: Diosmin 💬--3件: 46, 97, 265 💬
47Diosminex, 500 mg, tabletki powlekane----1件: 265 💬
48Dolutegravir1件: Dolutegravir1件: Dolutegravir 💬--2件: 2, 265 💬
49Dolutegravir / Lamivudine Oral Tablet2件: Dolutegravir,
Lamivudine		2件: Lamivudine ,
Dolutegravir 💬		--1件: 265 💬
50Dolutegravir 50 MG1件: Dolutegravir1件: Dolutegravir 💬--1件: 265 💬
51Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]2件: Dolutegravir,
Lamivudine		2件: Lamivudine ,
Dolutegravir 💬		--1件: 265 💬
52Doravirine1件: Doravirine1件: Doravirine 💬--1件: 265 💬
53Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]4件: Doravirine,
Lamivudine,
Tenofovir,
Tenofovir disoproxil		3件: Lamivudine ,
Tenofovir ,
Doravirine 💬		--1件: 265 💬
54Efavirenz1件: Efavirenz1件: Efavirenz 💬--1件: 265 💬
55Efavirenz (EFV)1件: Efavirenz1件: Efavirenz 💬--1件: 265 💬
56Emtricitabine1件: Emtricitabine1件: Emtricitabine 💬--4件: 25, 93, 265, 325 💬
57Emtricitabine/tenofovir2件: Emtricitabine,
Tenofovir		2件: Emtricitabine ,
Tenofovir 💬		--1件: 265 💬
58Enfuvirtide1件: Enfuvirtide1件: Enfuvirtide 💬--2件: 25, 265 💬
59Enfuvirtide (T20)1件: Enfuvirtide1件: Enfuvirtide 💬--1件: 265 💬
60Fenofibrate1件: Fenofibrate1件: Fenofibrate 💬1件: PPARA 💬10件: Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬6件: 8, 79, 93, 94, 97, 265 💬
61Gemcabene1件: Gemcabene---2件: 79, 265 💬
62Genotropin (human recombinant Growth hormone)1件: Somatotropin---1件: 265 💬
63Growth hormone1件: Somatotropin---14件: 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 276, 299 💬
64Growth Hormone Releasing Hormone1件: Somatotropin---1件: 265 💬
65GSK1265744B (sodium salt) containing 14C-GSK1265744B----1件: 265 💬
66High-carbohdyrate breakfast----1件: 265 💬
67High-dose REGN4461----1件: 265 💬
68HIV Anti-retroviral Background Therapy----1件: 265 💬
69Hu Leptin (A-100)1件: Leptin---1件: 265 💬
70Human Growth Hormone1件: Somatotropin---5件: 78, 187, 193, 265, 276 💬
71Human recombinant leptin (metreleptin)2件: Leptin,
Metreleptin		1件: Metreleptin 💬1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
72Indinavir1件: Indinavir1件: Indinavir 💬--1件: 265 💬
73ISIS 304801----1件: 265 💬
74Kaletra (lopinavir [LPVr])1件: Lopinavir1件: Lopinavir 💬--1件: 265 💬
75L-Carnitine1件: Levocarnitine1件: Levocarnitine 💬--7件: 13, 86, 96, 97, 265, 298, 316 💬
76Lamivudine1件: Lamivudine1件: Lamivudine 💬--7件: 2, 26, 42, 46, 135, 265, 325 💬
77Lamivudine/Zidovudine2件: Lamivudine,
Zidovudine		2件: Lamivudine ,
Zidovudine 💬		--1件: 265 💬
78Leptin1件: Leptin---2件: 6, 265 💬
79Lopinavir1件: Lopinavir1件: Lopinavir 💬--1件: 265 💬
80Lopinavir/Ritonavir2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬		--1件: 265 💬
81Lopinavir/ritonavir + nevirapine3件: Lopinavir,
Nevirapine,
Ritonavir		3件: Ritonavir ,
Nevirapine ,
Lopinavir 💬		--1件: 265 💬
82Lopinavir/ritonavir + zidovudine + lamivudine4件: Lamivudine,
Lopinavir,
Ritonavir,
Zidovudine		4件: Lamivudine ,
Zidovudine ,
Ritonavir ,
Lopinavir 💬		--1件: 265 💬
83Low-Dose REGN4461----1件: 265 💬
84Mecasermin1件: Mecasermin1件: Mecasermin 💬2件: GHR,
IGF1R 💬		33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬5件: 78, 96, 168, 265, 299 💬
85Metformin1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬25件: 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 218, 225, 233, 265, 285, 299, 301 💬
86METFORMIN HYDROCHLORIDE1件: Metformin1件: Metformin 💬2件: PRKAA1,
PRKAA2 💬		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬5件: 81, 158, 265, 299, 301 💬
87METRELEPTIN1件: Metreleptin1件: Metreleptin 💬1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
88Metrelpetin----1件: 265 💬
89Monotherapy (Lopinavir/ritonavir)2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬		--1件: 265 💬
90Monotherapy (Lopinavir/ritonavir) + ABC/3TC2件: Lopinavir,
Ritonavir		2件: Ritonavir ,
Lopinavir 💬		--1件: 265 💬
91Myalept1件: Metreleptin1件: Metreleptin 💬1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
92N-trans-3-Hexenoyl] Human Growth Hormone Releasing Factor (1-44) Acetate2件: Acetate,
Somatotropin		---1件: 265 💬
93Nelfinavir1件: Nelfinavir1件: Nelfinavir 💬--3件: 49, 265, 331 💬
94Nelfinavir mesylate1件: Nelfinavir1件: Nelfinavir 💬--1件: 265 💬
95Nevirapine1件: Nevirapine1件: Nevirapine 💬--1件: 265 💬
96Non-nucleoside reverse transcriptase inhibitors----1件: 265 💬
97Norvir1件: Ritonavir1件: Ritonavir 💬--2件: 265, 299 💬
98NucleomaxX----1件: 265 💬
99Nucleoside analogue sparing HAART regimen----1件: 265 💬
100Nucleoside reverse transcriptase inhibitors----1件: 265 💬
101Obeticholic Acid1件: Obeticholic acid1件: Obeticholic acid 💬1件: NR1H4 💬1件: Bile secretion 💬3件: 93, 265, 296 💬
102Pegvisomant1件: Pegvisomant1件: Pegvisomant 💬1件: GHR 💬5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 78, 265 💬
103Perform blood cells and fibroblasts biochemical and immuno-labeled investigations----1件: 265 💬
104Pioglitazone1件: Pioglitazone1件: Pioglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
105Pioglitazone or metformin2件: Metformin,
Pioglitazone		2件: Metformin ,
Pioglitazone 💬		3件: PPARG,
PRKAA1,
PRKAA2 💬		27件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 💬1件: 265 💬
106Pneumococcal polysaccharide vaccine 23 valent----1件: 265 💬
107Pravastatin1件: Pravastatin1件: Pravastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
108Pravastatin sodium1件: Pravastatin1件: Pravastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬1件: 265 💬
109Prevenar13----2件: 19, 265 💬
110Protease inhibitor----1件: 265 💬
111Protease inhibitors----1件: 265 💬
112R-metHuLeptin1件: Metreleptin1件: Metreleptin 💬1件: LEPR 💬6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 💬1件: 265 💬
113Raltegravir1件: Raltegravir1件: Raltegravir 💬--4件: 13, 26, 93, 265 💬
114RECOMBINANT HUMAN GROWTH HORMONE1件: Somatotropin---4件: 78, 193, 265, 276 💬
115Recombinant human growth hormone + rosiglitazone2件: Rosiglitazone,
Somatotropin		1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 265 💬
116REGN4461----1件: 265 💬
117Reyataz1件: Atazanavir1件: Atazanavir 💬--1件: 265 💬
118REYATAZ 150MG 60 CPS BL1件: Atazanavir1件: Atazanavir 💬--1件: 265 💬
119Riboflavin1件: Riboflavin1件: Riboflavin 💬--7件: 38, 46, 96, 97, 162, 168, 265 💬
120Ritonavir1件: Ritonavir1件: Ritonavir 💬--3件: 2, 86, 265 💬
121Ritonavir (Norvir)1件: Ritonavir1件: Ritonavir 💬--1件: 265 💬
122Rosiglitazone1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬5件: 46, 75, 97, 222, 265 💬
123Rosiglitazone maleate1件: Rosiglitazone1件: Rosiglitazone 💬1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬3件: 46, 75, 265 💬
124RTV----1件: 265 💬
125Saquinavir1件: Saquinavir1件: Saquinavir 💬--2件: 86, 265 💬
126Serostim®[somatropin (rDNA origin) for injection]1件: Somatotropin---1件: 265 💬
127Setmelanotide1件: Setmelanotide1件: Setmelanotide 💬1件: MC4R 💬1件: Neuroactive ligand-receptor interaction 💬2件: 202, 265 💬
128Simvastatin1件: Simvastatin1件: Simvastatin 💬1件: HMGCR 💬4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬21件: 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
129Somatropin1件: Somatotropin---19件: 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 💬
130ST200----1件: 265 💬
131Standard continuous antiretroviral therapy----1件: 265 💬
132Stavudine1件: Stavudine1件: Stavudine 💬--1件: 265 💬
133Sulfate1件: Sulfate ion---27件: 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 85, 86, 96, 111, 218, 222, 224, 226, 265, 296, 297, 299 💬
134SUSTIVA1件: Efavirenz1件: Efavirenz 💬--1件: 265 💬
135TAT4 Gel concentration A----1件: 265 💬
136TAT4 Gel concentration B----1件: 265 💬
137Tenofovir2件: Tenofovir,
Tenofovir disoproxil		1件: Tenofovir 💬--6件: 2, 13, 25, 93, 265, 325 💬
138Tenofovir DF1件: Tenofovir1件: Tenofovir 💬--1件: 265 💬
139Tenofovir disoproxil2件: Tenofovir,
Tenofovir disoproxil		1件: Tenofovir 💬--2件: 93, 265 💬
140Tenofovir Disoproxil Fumarate2件: Tenofovir,
Tenofovir disoproxil		1件: Tenofovir 💬--1件: 265 💬
141Tesamorelin1件: Tesamorelin1件: Tesamorelin 💬1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬2件: 78, 265 💬
142Tesamorelin (Egrifta)1件: Tesamorelin1件: Tesamorelin 💬1件: GHRHR 💬2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬1件: 265 💬
143TH9507----1件: 265 💬
144Thiamine1件: Thiamine1件: Thiamine 💬--3件: 8, 93, 265 💬
145Tipranavir1件: Tipranavir1件: Tipranavir 💬--1件: 265 💬
146Total Dietary Replacement----1件: 265 💬
147TRUVADA1件: Emtricitabine1件: Emtricitabine 💬--1件: 265 💬
148Use of lipid-lowering drugs.----1件: 265 💬
149Viral load driven treatment interruption----1件: 265 💬
150Volanesorsen1件: Volanesorsen1件: Volanesorsen 💬1件: APOC3 💬2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265 💬
151VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide1件: Volanesorsen1件: Volanesorsen 💬1件: APOC3 💬2件: Cholesterol metabolism, PPAR signaling pathway 💬1件: 265 💬
152Zidovudine1件: Zidovudine1件: Zidovudine 💬--6件: 25, 26, 135, 265, 325, 331 💬